Influence of intrinsic radiosensitivity on the survival of breast cancer patients.
Affiliation
Biostatistics Group, School of Epidemiology and Health Sciences, University of Manchester, Manchester M13 9PT, UK. steve.roberts@man.ac.ukIssue Date
2003-05
Metadata
Show full item recordAbstract
PURPOSE: The association between enhanced intrinsic radiosensitivity, measured by the level of chromosome damage induced in either the G2 or G0 phases of the cell cycle, and the risk of breast cancer has been well demonstrated. Although not originally designed for this purpose, early studies are now sufficiently mature (median follow-up 4.2 years) to enable an assessment of the impact of radiosensitivity on patient outcome. MATERIALS AND METHODS: Breast cancer patients assessed in previous studies of G2 and G0 lymphocyte chromosomal radiosensitivity between 1993 and 1997 were identified. Tumour characteristics, recurrence and survival data were obtained from clinical records and outcomes were compared between those identified as having normal and elevated radiosensitivity in the two assays. RESULTS: There was a significant association between G0 sensitivity and tumour grade (p=0.03), but otherwise there were no associations in these series between radiosensitivity in the two assays and tumour characteristics. Overall survival in this cohort of patients was high (94% at 5 years) and there was no association between the G2 or G0 assay results and outcome as measured by cancer-specific survival or local recurrence. CONCLUSIONS: Radiosensitivity, as measured by these two assays, was not a strong prognostic factor following standard radiotherapy treatment. However, the statistical power of the present study was limited and modest prognostic utility could not be discounted. Further studies designed specially to investigate outcome are needed, possibly in association with trials of altered radiotherapy fractionation.Citation
Influence of intrinsic radiosensitivity on the survival of breast cancer patients. 2003, 79 (5):311-7 Int. J. Radiat. Biol.Journal
International Journal of Radiation BiologyDOI
10.1080/0955300031000137797PubMed ID
12943239Type
ArticleLanguage
enISSN
0955-3002ae974a485f413a2113503eed53cd6c53
10.1080/0955300031000137797
Scopus Count
Related articles
- Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays.
- Authors: Scott D, Barber JB, Spreadborough AR, Burrill W, Roberts SA
- Issue date: 1999 Jan
- Chromosomal radiosensitivity in Ukrainian breast cancer patients and healthy individuals.
- Authors: Ryabchenko NM, Glavin OA, Shtefura VV, Anikushko MF
- Issue date: 2012 Jul
- Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer.
- Authors: Hoeller U, Borgmann K, Bonacker M, Kuhlmey A, Bajrovic A, Jung H, Alberti W, Dikomey E
- Issue date: 2003 Nov
- Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition.
- Authors: Baeyens A, Thierens H, Claes K, Poppe B, Messiaen L, De Ridder L, Vral A
- Issue date: 2002 Dec 2
- Chromosomal radiosensitivity, cancer predisposition and response to radiotherapy.
- Authors: Scott D
- Issue date: 2000 May